Reset filters
  • 27 October 2008

No significant differences between elvucitabine and 3TC at 48 weeks

Read the article
  • 27 October 2008

Raltegravir non-inferior to efavirenz: 48 week, phase III results

Read the article
  • 23 October 2008

CD4 decline, death more likely if change from NNRTI regimen delayed

Read the article
  • 23 October 2008

Efavirenz superior to nevirapine for first-line treatment: African observational cohort

Read the article
  • 22 October 2008

Is there a role for tropism testing in routine HIV care?

Read the article
  • 22 October 2008

HIV-associated immunosuppression increases risk of liver cancer

Read the article
  • 22 October 2008

Once-daily darunavir (Prezista) approved for first-line use in United States

Read the article
  • 21 October 2008

Shorter combination TB preventive regimens may be effective alternative to six-month isoniazid preventive therapy

Read the article
  • 20 October 2008

UK conference discusses ‘disastrous’ impact of the myth of ‘HIV health tourism’

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.